Hossam El Benawi: Intensive Blood Pressure Reduction May Worsen Outcomes After Thrombectomy
Hossam El Benawi, Senior Clinical Research Fellow of Cardiovascular Medicine at Mayo Clinic, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Our Analysis does not support intensive systolic blood pressure lowering after successful thrombectomy following ischemic stroke and instead support the use of a standard, permissive (systolic blood pressure <180 mm Hg) management strategy as the current standard of care to optimize patient recovery.
After successful thrombectomy following acute Ischemic Stroke:
- Maintaining systolic BP <180 mm Hg is associated with better outcomes.
- Targeting systolic BP <140 mm Hg after thrombectomy may be harmful – inked to worse functional outcomes at 90 days across the modified Rankin Scale.
All Credits to the talented Ahmed Ibrahim leading this efforts.”
Title: Intensive Versus Standard Systolic Blood Pressure largets Following Successtul Endovascular Thrombectomy for Acute Ischemic Stroke: A Systematic Review With Frequentist and Bayesian Meta-Analysis
Authors: Ahmed Ibrahim, AlMothana Manasrah, M Rafiqul Islam, Ibrahim Khalil, Ali Saad Al-Shammari, Sohaila Mourad, Elsayed Balbaa, Hossam Elbenawi, Yasar Sattar, Aristeidis Katsanos, Giuseppe Ando
Read the Full Article.

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 16, 2026, 10:31Erhabor Osaro: Critical Issues to Consider During the Clinical Blood Transfusion Process
-
Aug 16, 2026, 10:14Juan Manuel Cisneros Carrasco: The Architects Behind the Blood Donation System
-
Aug 16, 2026, 10:06Honoring the Life and Legacy of Dr. Reed Pyeritz – GADA Canada
-
Aug 16, 2026, 09:51Javier Amador-Castañeda: When a 32 Percent Reduction Tells Only Part of the Story
-
Aug 16, 2026, 09:33Anıl Güneş: The Unseen Threat – How Global Climate Change Impacts Cardiovascular Health
-
Aug 16, 2026, 09:09Robert John Nesbitt: Can We Prevent Stroke Without Increasing Bleeding Risk
-
Aug 16, 2026, 06:19Dennis Wolf: Is ZEUS the End of Anti-Inflammatory Therapy in Atherosclerosis?
-
Aug 16, 2026, 06:05Nicolas Hubacz: A New Target for Stroke Recovery
-
Aug 15, 2026, 19:30José Luis Neyro: E4 and DRSP Reduce Hirsutism While Showing Comparable Effects on Thrombin Generation